 The IMPROVA study is designed to identify novel predictors of vascular access success or failure. Clinical assessment complimented by Doppler ultrasound is the only currently employed methods of assessing suitability for placement of arteriovenous fistulae AVF. These techniques are not capable of predicting vascular access outcomes suggesting that other potentially measurable factors may play a part. 